Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effects of Glucosamine and Chondroitin Sulfate Supplementation in Addition to Resistance Exercise Training and Manual Therapy in Patients With Knee Osteoarthritis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04654871
Recruitment Status : Completed
First Posted : December 4, 2020
Last Update Posted : December 4, 2020
Sponsor:
Information provided by (Responsible Party):
Foundation University Islamabad

Brief Summary:
Osteoarthritis (OA) IS one of the most common joint disorders, affecting not only the joints but also the surrounding muscles, which become weak. Resistance exercise reduces pain and improves function in patients with OA of the knee. Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used by patients with OA to reduce pain and thereby maintain the ability to perform daily activities. However, there is accumulating evidence for a negative effect of NSAIDs, thus many patients with OA are treated with dietary supplementations such as glucosamine and chondroitin sulfate, and some studies show a beneficial effects on cartilage and pain. However, their effect on OA symptoms and cartilage remains controversial. Thus, it is important to investigate whether a potentially beneficial effect of glucosamine and chondroitin sulfate with resistance exercise and manual therapy in patients with knee OA.

Condition or disease Intervention/treatment Phase
Osteoarthritis Osteoarthritis, Knee Dietary Supplement: Chondroitin Sulfate Procedure: Resistance exercise training Procedure: Manual therapy / Joint Mobilization Procedure: THE therapy Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 24 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Effects of Glucosamine and Chondroitin Sulfate Supplementation in Addition to Resistance Exercise Training and Manual Therapy in Patients With Knee Osteoarthritis
Actual Study Start Date : January 1, 2020
Actual Primary Completion Date : September 1, 2020
Actual Study Completion Date : November 1, 2020

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Osteoarthritis

Arm Intervention/treatment
Experimental: Experimental Group Dietary Supplement: Chondroitin Sulfate
Glucosamine 500 mg Chondroitin sulfate sodium 400mg 3/day

Procedure: Resistance exercise training

Treadmill walking 5-10 min for warm up Strength training: (80% of 8RM)

Supervised exercise thrice a week and Home Exercise 4 times a week Leg press knee extension Knee flexion Terminal knee extension Mini squats 3 sets 8 reps 10-15 s rep rest interval 1-2 min set rest interval


Procedure: Manual therapy / Joint Mobilization
Ant. tib-fem glide Post tib-fem glide thrice a week Pattelo-femoral joint mobilization

Procedure: THE therapy
Interferential and Heating for 20 min

Experimental: Active Comparator Group Procedure: Resistance exercise training

Treadmill walking 5-10 min for warm up Strength training: (80% of 8RM)

Supervised exercise thrice a week and Home Exercise 4 times a week Leg press knee extension Knee flexion Terminal knee extension Mini squats 3 sets 8 reps 10-15 s rep rest interval 1-2 min set rest interval


Procedure: Manual therapy / Joint Mobilization
Ant. tib-fem glide Post tib-fem glide thrice a week Pattelo-femoral joint mobilization

Procedure: THE therapy
Interferential and Heating for 20 min




Primary Outcome Measures :
  1. Visual Analogue Scale [ Time Frame: 2 weeks ]
    Visual Analogue Scale was used to measure pain scoring from 0-10 cm on a horizontal 10cm line. A greater score reflects higher pain intensity.

  2. Visual Analogue Scale [ Time Frame: 4 weeks ]
    Visual Analogue Scale was used to measure pain scoring from 0-10 cm on a horizontal 10cm line. A greater score reflects higher pain intensity.

  3. Knee Injury and Osteoarthritis Outcome Score [ Time Frame: 2 weeks ]
    Knee Injury and Osteoarthritis Outcome Score (KOOS) to measure physical function and quality of life. A greater score on Knee Injury and Osteoarthritis Outcome Score reflects good prognosis and outcome and a lower score shows poor prognosis and outcome. the score for Knee Injury and Osteoarthritis Outcome Score is reported in the form of percentage i.e. 0-100%.

  4. Knee Injury and Osteoarthritis Outcome Score [ Time Frame: 4 weeks ]
    Knee Injury and Osteoarthritis Outcome Score (KOOS) to measure physical function and quality of life. A greater score on Knee Injury and Osteoarthritis Outcome Score reflects good prognosis and outcome and a lower score shows poor prognosis and outcome. the score for Knee Injury and Osteoarthritis Outcome Score is reported in the form of percentage i.e. 0-100%.

  5. Knee Joint Range of Motion [ Time Frame: 2 weeks ]
    Knee Joint Range of Motion will be measured via goniometry. It is a continuous scale and a greater score reflects greater angular movement possible at the knee joint, which is measured in degrees.

  6. Knee Joint Range of Motion [ Time Frame: 4 weeks ]
    Knee Joint Range of Motion will be measured via goniometry. It is a continuous scale and a greater score reflects greater angular movement possible at the knee joint, which is measured in degrees.

  7. Body Composition [ Time Frame: 2 weeks ]
    Body Composition was measured via bioelectrical impedance analysis. A greater Phase angle reflects better cellular integrity and smaller phase angle reflects poorer cellular integrity.

  8. Body Composition [ Time Frame: 4 weeks ]
    Body Composition was measured via bioelectrical impedance analysis. A greater Phase angle reflects better cellular integrity and smaller phase angle reflects poorer cellular integrity.

  9. Fall risk [ Time Frame: 2 weeks ]
    Fall risk will be measured via Biodex balance system, and greater score reflects greater fall risk and poorer outcome.

  10. Fall risk [ Time Frame: 4 weeks ]
    Fall risk will be measured via Biodex balance system, and greater score reflects greater fall risk and poorer outcome.

  11. 5 repetition sit to stand test [ Time Frame: 2 weeks ]
    Time will be measured to perform 5 repetitions of sit to stand activity. Lesser time means a better score.

  12. 5 repetition sit to stand test [ Time Frame: 4 weeks ]
    Time will be measured to perform 5 repetitions of sit to stand activity. Lesser time means a better score.

  13. Modified sphygmomanometer dynamometry [ Time Frame: 2 weeks ]
    Modified sphygmomanometer dynamometry was used to measure muscle strength. Greater score will reflect greater muscle strength. The unit of Modified sphygmomanometer dynamometry used will be mmHg (millimeter of mercury).

  14. Modified sphygmomanometer dynamometry [ Time Frame: 4 weeks ]
    Modified sphygmomanometer dynamometry was used to measure muscle strength. Greater score will reflect greater muscle strength. The unit of Modified sphygmomanometer dynamometry used will be mmHg (millimeter of mercury).



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   40 Years to 70 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • knee osteoarthritis for at least 3 months
  • knee pain no more than 8/10
  • Grade III or less on radiograph (Kellgren classification)

Exclusion Criteria:

  • Malignancy
  • Any additional Inflammatory disorders
  • Infection
  • Knee trauma
  • lower limb fracture
  • Lumbar radiculopathy or myelopathy
  • knee surgery or replacement
  • Intra-articular steroid therapy in the last 2 months

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04654871


Locations
Layout table for location information
Pakistan
Foundation University Institute of Rehabilitation Sciences.
Islamabad, Federal, Pakistan, 46000
Sponsors and Collaborators
Foundation University Islamabad
Layout table for additonal information
Responsible Party: Foundation University Islamabad
ClinicalTrials.gov Identifier: NCT04654871    
Other Study ID Numbers: FUI/CTR/2020/11
First Posted: December 4, 2020    Key Record Dates
Last Update Posted: December 4, 2020
Last Verified: December 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Foundation University Islamabad:
chondroitin sulfate
resistance exercise
strength training
manual therapy
glucosamine
joint mobilization
Additional relevant MeSH terms:
Layout table for MeSH terms
Osteoarthritis
Osteoarthritis, Knee
Arthritis
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases